solutions phase-ii-iv site-start Clinical Development Related Topics 
XTalks
AUGUST 2, 2023
The company also continued the implementation of some global restructuring plans started in previous years, as well as initiating a portfolio prioritization program for their Pharmaceutical division. M-M-R II was approved even earlier, in 1978. The cost of Januvia is around $664 for a 30-day supply (without insurance). billion in 2022.
XTalks
SEPTEMBER 14, 2020
As of July, the company and its federal partner stated that it is on track to supply between 500 million to 1 billion doses a year at a dose of 100 µg now selected for their Phase III trial. Novavax has also tested its recombinant SARS-CoV-2 nanoparticle adjuvanted vaccine in a Phase I/II trial. Novavax’ COVID-19 Vaccine.
Expert insights. Personalized for you.
98 
Let's personalize your content